FRATERNALE, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 10.542
EU - Europa 7.024
AS - Asia 3.813
SA - Sud America 396
Continente sconosciuto - Info sul continente non disponibili 238
AF - Africa 56
OC - Oceania 25
AN - Antartide 1
Totale 22.095
Nazione #
US - Stati Uniti d'America 10.372
GB - Regno Unito 2.146
IT - Italia 1.780
CN - Cina 1.746
SG - Singapore 1.128
UA - Ucraina 737
RU - Federazione Russa 568
SE - Svezia 448
FI - Finlandia 374
DE - Germania 354
BR - Brasile 300
TR - Turchia 298
VN - Vietnam 209
FR - Francia 180
IE - Irlanda 171
CA - Canada 108
IN - India 98
PL - Polonia 59
JP - Giappone 55
BD - Bangladesh 44
KR - Corea 43
MX - Messico 42
NL - Olanda 41
HK - Hong Kong 40
AR - Argentina 35
BE - Belgio 35
ES - Italia 28
IQ - Iraq 23
PK - Pakistan 23
ZA - Sudafrica 22
IR - Iran 20
AT - Austria 19
AU - Australia 17
EC - Ecuador 17
PT - Portogallo 16
CO - Colombia 13
EU - Europa 12
SA - Arabia Saudita 12
AE - Emirati Arabi Uniti 11
LT - Lituania 11
JO - Giordania 10
RO - Romania 10
MA - Marocco 9
CL - Cile 8
ID - Indonesia 7
IL - Israele 7
NZ - Nuova Zelanda 7
DK - Danimarca 6
KZ - Kazakistan 6
PE - Perù 6
UY - Uruguay 6
AZ - Azerbaigian 5
EE - Estonia 5
EG - Egitto 5
JM - Giamaica 5
MY - Malesia 5
PY - Paraguay 5
UZ - Uzbekistan 5
BG - Bulgaria 4
CI - Costa d'Avorio 4
GR - Grecia 4
LV - Lettonia 4
PA - Panama 4
TG - Togo 4
VE - Venezuela 4
GT - Guatemala 3
HR - Croazia 3
HU - Ungheria 3
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
CY - Cipro 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
IS - Islanda 2
KH - Cambogia 2
LU - Lussemburgo 2
MD - Moldavia 2
NP - Nepal 2
SI - Slovenia 2
SM - San Marino 2
TN - Tunisia 2
TW - Taiwan 2
AL - Albania 1
AM - Armenia 1
AQ - Antartide 1
BH - Bahrain 1
BW - Botswana 1
DJ - Gibuti 1
GD - Grenada 1
HN - Honduras 1
KG - Kirghizistan 1
KY - Cayman, isole 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MK - Macedonia 1
MU - Mauritius 1
Totale 21.858
Città #
Southend 1.890
Fairfield 1.147
Ashburn 1.068
Woodbridge 912
Houston 809
Ann Arbor 768
Singapore 575
Jacksonville 569
Seattle 469
San Jose 467
Cambridge 462
Chandler 455
Urbino 421
Wilmington 396
Dallas 289
Nanjing 281
Beijing 276
Izmir 208
Helsinki 201
Boardman 196
Dublin 166
New York 142
Los Angeles 130
Nanchang 113
Council Bluffs 109
Lauterbourg 98
Princeton 91
San Mateo 85
Ho Chi Minh City 79
Munich 74
Shenyang 73
Rome 72
Düsseldorf 63
Santa Clara 60
London 59
Bremen 56
Tianjin 55
Istanbul 53
Hebei 52
Jiaxing 50
San Diego 50
Toronto 49
Moscow 46
Milan 45
São Paulo 44
Changsha 43
Hanoi 43
Guangzhou 41
Shanghai 41
Warsaw 41
Orem 40
Hong Kong 35
Brussels 34
Buffalo 32
Bologna 30
Frankfurt am Main 30
Jinan 30
Kunming 29
Seongnam 29
Denver 28
Chennai 27
Hangzhou 27
The Dalles 27
Chicago 25
Montreal 25
San Francisco 25
Tokyo 25
Redondo Beach 23
Turku 23
Mülheim 22
Velikiy Novgorod 22
Brooklyn 21
Ancona 20
Poplar 19
Stockholm 19
Amsterdam 18
Johannesburg 18
Manchester 18
Rimini 18
Bellaria-Igea Marina 16
Dong Ket 16
Macerata 16
Mumbai 16
Calcinelli 15
Mexico City 15
Phoenix 15
Turin 15
Zhengzhou 15
Ankara 13
Atlanta 13
Ravenna 13
Boston 12
Nuremberg 12
Redwood City 12
Vienna 12
Pescara 11
Portsmouth 11
Taizhou 11
Auburn Hills 10
Changchun 10
Totale 15.000
Nome #
Targeting SARS-CoV-2 by synthetic dual-acting thiol compounds that inhibit Spike/ACE2 interaction and viral protein production 555
Glutathione Depletion Is Linked with Th2 Polarization in Mice with a Retrovirus-Induced Immunodeficiency Syndrome, Murine AIDS: Role of Proglutathione Molecules as Immunotherapeutics 435
Metodo di sintesi di derivati del glutatione [Method for the synthesis of glutathione derivatives] 333
Antiviral and Immunomodulatory Properties of New Pro-Glutathione (GSH) Molecules. 311
Polarization and repolarization of macrophages 309
Design, synthesis and biological activity of hydrogen peroxide responsive arylboronate melatonin hybrids 301
Glutathione increase by the n‐butanoyl glutathione derivative (GSH‐C4) inhibits viral replication and induces a predominant Th1 immune profile in old mice infected with influenza virus 298
Effect of the N‑butanoyl glutathione (GSH) derivative and acyclovir on HSV‑1 replication and Th1 cytokine expression in human macrophages 297
The increase in intra-macrophage thiols induced by new pro-GSH molecules directs the Th1 skewing in ovalbumin immunized mice 288
Antitumoral activity of indole-3-carbinol cyclic tri- and tetrameric derivatives mixture in human breast cancer cells: in vitro and in vivo studies 286
Dexamethasone improves redox state in ataxia telangiectasia cells by promoting an NRF2-mediated antioxidant response 286
A new one-step RT-PCR method for virus quantitation in murine AIDS. 283
2',3'-Dideoxycytidine induced drug resistance in human cells 279
Inhibition of murine AIDS by pro-glutathione (GSH) molecules 278
2',3'-Dideoxycytidine metabolism in a new drug-resistant cell line 272
Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS (MAIDS) 267
Erythrocytes as carriers of antisense PNA addressed against HIV-1 gag-pol transframe domain 266
Molecules Altering the Intracellular Thiol Content Modulate NF-kB and STAT-1/IRF-1 Signalling Pathways and IL-12 p40 and IL-27 p28 Production in Murine Macrophages 266
Administration of fludarabine-loaded autologous red blood cells in simian immunodeficiency virus-infected sooty mangabeys depletes pSTAT-1-expressing macrophages and delays the rebound of viremia after suspension of antiretroviral therapy. 262
I-152, a supplier of N-acetyl-cysteine and cysteamine, inhibits immunoglobulin secretion and plasma cell maturation in LP-BM5 murine leukemia retrovirus-infected mice by affecting the unfolded protein response 262
Red Blood Cell-Based Delivery of Drugs and Nanomaterials for Therapeutic and Diagnostic Applications 260
Modulation of Th1/Th2 immune responses to HIV-1 Tat by new pro-GSH molecules 259
Comparison of novel delivery systems for antisense peptide nucleic acids 256
Drug delivery through phagocytosis of red blood cells 253
Erythrocyte-based drug delivery 252
Species-dependent chromium accumulation, lipid peroxidation, and glutathione levels in germinating kiwifruit pollen under Cr(III) and Cr(VI) stress 251
Synthesis and Biological Evaluation of a γ-Cyclodextrin-based Formulation of the Anticancer Agent 5,6,11,12,17,18,23,24-Octahydrocyclododeca[1,2-b:4,5-b’:7,8-b’’:10,11-b’’’]tetraindole (CTet) 246
Pharmaceutical composition or composition package containing a pyrimidine nucleoside analog and a purine nucleoside analog 245
Drug delivery by red blood cells 243
Development of a real-time PCR assay using SYBR Green I for provirus load quantification in a murine model of AIDS 240
Targeting antiviral nucleotide analogues to macrophages 240
Polyphenol-enriched spelt husk extracts improve growth and stress-related biochemical parameters under moderate salt stress in maize plants 240
Validation of a Reversed-Phase High Performance Liquid Chromatography method for the simultaneous analysis of cysteine and reduced glutathione in mouse organs 238
Activation of NRF2 and ATF4 Signaling by the Pro-Glutathione Molecule I-152, a Co-Drug of N-Acetyl-Cysteine and Cysteamine 238
LDL receptors, caveolae and cholesterol in endothelial dysfunction: oxLDLs accomplices or victims? 237
Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model. 234
Inhibition of macrophage iNOS by selective targeting of antisense PNA. 233
Inhibition of murine AIDS by combination of AZT and dideoxycytidine 5'-triphosphate 233
Large-Scale Preparation of N-Butanoyl-l-glutathione (C4-GSH) 232
Glutathione and glutathione derivatives in immunotherapy 231
Antiretroviral effect of combined zidovudine and reduced glutathione therapy in murine AIDS. 227
Mechanisms of action and antiproliferative properties of URB631 in human breast cancer 219
Repeated cycles of alternate administration of fludarabine and zidovudine plus didanosine inhibits murine AIDS and reduces proviral DNA content in lymph nodes to undetectable levels 216
The indole-3-carbinol tetrameric derivative CTet inhibits cell proliferation via overexpression of p21/CDKN1A in both estrogen receptor-positive and triple-negative breast cancer cell lines 215
Redox homeostasis as a target for new antimycobacterial agents 215
Inhibition of murine AIDS by reduced glutathione. 214
Boosting GSH Using the Co-Drug Approach: I-152, a Conjugate of N-acetyl-cysteine and β-mercaptoethylamine 214
Indole-3-carbinol (I3C) Tetrameric Derivative (CTet) Inhibits Cell Cycle Progression Inducing Overexpression of p21/cip1/waf1 and GADD45A in Breast Cancer Cell Lines 213
New treatment protocol including lympholytic and antiretroviral drugs to inhibit murine AIDS 212
Redox-regulation of the influenza hemagglutinin maturation process: a new cell-mediated strategy for anti-influenza therapy 212
Red Blood Cell Membrane Processing for Biomedical Applications 211
Targeting nucleotide dimers containing antiviral nucleosides 207
Macrophage protection by nucleoside and nucleotide analogue administration 195
A new humanized antibody is effective against pathogenic fungi in vitro 194
Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides 191
Normalization of hyperglycemia in diabetic mice by enzyme-loaded erythrocytes 190
Up-regulation of the ubiquitin-conjugating and proteolytic systems in murine acquired immunodeficiency syndrome 189
Red blood cell phagocytosis following hexokinase inactivation. 189
Inhibition of murine AIDS by combination of AZT and DDCTP-loaded erythrocytes 187
Inhibition of Murine AIDS by a New Azidothymidine Homodinucleotide. 184
Synthesis and targeted delivery of an azidothymidine homodinucleotide conferring protection to macrophages against retroviral infection 183
FIV infection of macrophages: in vitro and in vivo inhibition by dideoxycytidine-5'-triphosphate. 182
Modulated red blood cell survival by membrane protein clustering 181
GSH and analogs in antiviral therapy 180
Azidothymidine homodinucleotide-loaded erythrocytes and bioreactors for slow delivery of the antiretroviral drug azidothymidine 179
In vivo survival and in vitro phagocytosis of engineered erythrocytes. 178
Efficacy and toxicity of long-term administration of 2',3'-dideoxycytidine in the LP-BM5 murine-induced immunodeficiency model 178
Erythrocyte-based targeted release to macrophages of an azidothymidine homodinucleotide prevents retroviral infection 176
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 176
Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression. 174
Liposomes as carriers of the antiretroviral agent dideoxycytidine-5'-triphosphate. 172
Dynamic changes in immunoproteasome assembly and capping with regulatory particles in an invitro model of senescing macrophages 171
GSH-C4 Acts as Anti-inflammatory Drug in Different Models of Canonical and Cell Autonomous Inflammation Through NFκB Inhibition 170
Erythrocytes as carriers of reduced glutathione (GSH) in the treatment of retroviral infections 168
Targeting antiviral nucleotide analogues to macrophages 165
Inhibition of murine AIDS by alternate administration of azidothimidine and fludarabine monofosfate. 165
Fludarabine delivery by autologous red blood cells induces macrophage depletion in chronically SIV-infected Sooty Mangabeys. 165
Dithiol Based on L-Cysteine and Cysteamine as a Disulfide-Reducing Agent 164
A synthetic thiol molecule releasing N-acetyl-l-cysteine and cysteamine drives early up-regulation of immunoproteasome subunits in the lymph nodes of mice infected with LP-BM5 leukemia retrovirus 160
Macrophage depletion by Clodronate-loaded erythrocytes 159
Red blood cells as carriers of drugs against retroviruses 159
Effect of antiviral treatments on the bone marrow in murine AIDS 157
Functionalized 3D scaffolds for engineering the hematopoietic niche 155
Role of macrophage protection in the development of murine AIDS. 154
Intracellular Redox-Modulated Pathways as Targets for Effective Approaches in the Treatment of Viral Infection 154
New drug combinations for the treatment of murine AIDS and macrophage protection. 151
Macrophage long-term cultures as a cellular model of senescence to study proteostasis in aging immune cells 148
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 148
Encapsulation of DDCTP in feline erythrocytes and inhibition of FIV infection. 146
Redox modulation via a synthetic thiol compound reshapes energy metabolism in endothelial cells and ameliorates angiogenic expression in a co-culture study with activated macrophages 135
Multitalented Synthetic Antimicrobial Peptides and Their Antibacterial, Antifungal and Antiviral Mechanisms 135
Encapsulation, metabolism and release of 2-fluoro-ara-AMP from human erythrocytes. 134
Inhibition of murine retrovirus-induced immunodeficiency disease by dideoxycytidine and dideoxycytidine 5'-triphosphate. 133
Colostrum and milk EVs from Water Buffalo enhance phagocytosis in macrophages and improve ATP production in human intestinal cell line 131
The influence of redox modulation on hypoxic endothelial cell metabolic and proteomic profiles through a small thiol-based compound tuning glutathione and thioredoxin systems 128
Anoxia Rapidly Induces Changes in Expression of a Large and Diverse Set of Genes in Endothelial Cells 125
Intracellular redox state as target for influenza therapy: Are antioxidants always effective? 123
A microplate-based DCFH-DA assay for the evaluation of oxidative stress in whole semen 119
Specific targeting of antisense PNA by erythrocytes for the inhibition of nitric oxide production in murine macrophages 118
Dexamethasone effects in Ataxia Telangiectasia cell metabolism. 117
Totale 21.305
Categoria #
all - tutte 77.638
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.638


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.081 0 100 102 157 55 63 53 84 82 77 47 261
2022/20232.061 182 81 56 165 180 324 14 121 442 163 225 108
2023/2024682 56 27 38 106 52 170 23 48 16 66 7 73
2024/20251.997 101 79 378 133 92 128 279 86 201 171 205 144
2025/20265.017 479 390 524 852 496 372 611 165 362 485 201 80
2026/2027236 144 92 0 0 0 0 0 0 0 0 0 0
Totale 22.095